In light of the rapidly changing coronavirus (COVID-19) situation, Troutman Sanders and Pepper Hamilton have postponed the effective date of their previously announced merger until July 1, 2020. The new firm – Troutman Pepper – will feature 1,100+ attorneys across 23 U.S. offices. Read more.
Barry H. Boise, a partner and vice chair of the firm's Health Sciences Department, will be speaking at the American Conference Institute's (ACI's) 34th Annual FDA Boot Camp taking place on September 18–19, 2019 in Boston, MA. Mr. Boise will be joining the panel discussion titled "Understanding How FDARA and the 21st Century Cures Act Are Impacting Drug Approvals Through New Evidentiary Requirements" on September 18 at 11:15 AM.
The FDA Boot Camp is the premier event designed to provide professionals working in the life sciences space – such as patent and products litigators, in-house counsel, regulatory affairs specialists, business executives, and investors – a strong working knowledge of core FDA competencies. In addition to providing a “101” training, the event's updated agenda offers advanced guidance sessions discussing the pathways to approval, a patent and IP overview for pharmaceuticals, post-approval issues, and recalls and withdrawals. In addition, each step of the process comes with strategies to apply this knowledge to real-life situations.
The Bostonian Hotel
26 North Street
Boston, MA 02109
Register by July 12: $1,995
Register by September 17: $2,295